Arcellx, Inc. ($ACLX)
Filing Information
| Accession Number | 0001193125-26-005096 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
152,918
Total Value
$0.00
P&L
+inf% (+$7,770,847.16)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 13,021 | $0.00 | $0.00 | 13,615 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jan 3, 2026 | Exercise/Conversion | 16,520 | $0.00 | $0.00 | 30,135 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jan 6, 2026 | Exercise/Conversion | 13,064 | $0.00 | $0.00 | 43,199 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | Jan 2, 2026 | Grant/Award | 67,708 | $0.00 | $0.00 | 67,708 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | Jan 2, 2026 | Exercise/Conversion | 13,021 | $0.00 | $0.00 | 13,021 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | Jan 3, 2026 | Exercise/Conversion | 16,520 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | Jan 6, 2026 | Exercise/Conversion | 13,064 | $0.00 | $0.00 | 39,194 | Direct | โ | View Details |